| Title |
Atypical antipsychotics for psychosis in adolescents
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2013
|
| DOI | 10.1002/14651858.cd009582.pub2 |
| Pubmed ID | |
| Authors |
Ajit Kumar, Soumitra S Datta, Stephen D Wright, Vivek A Furtado, Paul S Russell |
| Abstract |
Schizophrenia often presents in adolescence, but current treatment guidelines are based largely on studies of adults with psychosis. Over the past decade, the number of studies on treatment of adolescent-onset psychosis has increased. The current systematic review collates and critiques evidence obtained on the use of various atypical antipsychotic medications for adolescents with psychosis. |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 25% |
| United Kingdom | 2 | 17% |
| Chile | 1 | 8% |
| India | 1 | 8% |
| Australia | 1 | 8% |
| Unknown | 4 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 75% |
| Practitioners (doctors, other healthcare professionals) | 3 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 361 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | <1% |
| Sweden | 1 | <1% |
| Denmark | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 357 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 61 | 17% |
| Researcher | 43 | 12% |
| Student > Bachelor | 41 | 11% |
| Student > Ph. D. Student | 33 | 9% |
| Other | 21 | 6% |
| Other | 59 | 16% |
| Unknown | 103 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 93 | 26% |
| Psychology | 42 | 12% |
| Nursing and Health Professions | 34 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 4% |
| Social Sciences | 15 | 4% |
| Other | 43 | 12% |
| Unknown | 118 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 October 2019.
All research outputs
#1,871,208
of 22,727,570 outputs
Outputs from Cochrane database of systematic reviews
#4,160
of 12,315 outputs
Outputs of similar age
#18,337
of 210,772 outputs
Outputs of similar age from Cochrane database of systematic reviews
#79
of 205 outputs
Altmetric has tracked 22,727,570 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,315 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one has gotten more attention than average, scoring higher than 66% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,772 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 205 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.